Importantly, the BCL-XL-selective inhibitor A-1155463 is not efficacious as a single agent or in combination with MCL-1 inhibitors in BCL2High NHL cell lines in vitro. This evidence concerns the gene MCL1 and non-Hodgkin lymphoma.